CDYL2

Chr 16

chromodomain Y like 2

Also known as: PCCP1

Predicted to enable transcription corepressor activity. Predicted to be involved in chromatin organization and negative regulation of DNA-templated transcription. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
3
Pubs (1 yr)
P/LP submissions
P/LP missense
0.60
LOEUF
DN
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.60LOEUF
pLI 0.019
Z-score 2.95
OE 0.32 (0.180.60)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
-0.11Z-score
OE missense 1.02 (0.931.12)
305 obs / 299.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.32 (0.180.60)
00.351.4
Missense OE?1.02 (0.931.12)
00.61.4
Synonymous OE?1.31
01.21.6
LoF obs/exp: 7 / 21.9Missense obs/exp: 305 / 299.8Syn Z: -2.80

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

CDYL2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →